Carregant...
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
OBJECTIVE: Ivabradine, a specific heart rate lowering therapy, has been shown in a randomised placebo-controlled study, Systolic HF Treatment with the I(f) Inhibitor Ivabradine Trial (SHI(f)T), to significantly reduce the composite end point of cardiovascular death and hospitalisation for worsening...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078716/ https://ncbi.nlm.nih.gov/pubmed/24634022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2013-304598 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|